向血管生成:人参化物的作用和作用机制
Ya-Wei Lu1, Jing-Tian Zhang1, Chen Chen2
1College of Chinese Medicinal Materials, Jilin Provincial International Joint Research Center for the Development and Utilization of Authentic Medicinal Materials, Jilin Agricultural University, Changchun 130118, China.
概括
人参中的化合物金色化物可以以双重的方式调节血管形成 (血管生成),为各种疾病提供新的治疗策略. 它们与生物材料的结合提高了治疗的有效性和安全性.
科学领域:
- 生物医学科学 生物医学科学
- 药理学 药理学是指药理学的学科.
- 再生医学是一种再生医学.
背景情况:
- 血管新生在生理和病理过程中至关重要,包括组织修复,瘤生长和缺血性疾病.
- 人参的关键成分 - - 人参酸,对血管生成具有独特的双向调节作用.
- 人参化物在各种疾病中的精确机制仍然不完全理解.
研究的目的:
- 通过多个信号通路全面审查银酸的血管生成双向调节.
- 探索血管新生相关疾病的新型治疗策略.
- 评估与生物材料相结合的金色化物应用前景.
主要方法:
- 在PubMed,科学网,CNKI和Science Direct的系统文献搜索,截至2025年5月.
- 关键词包括"血管新生","阴道酸"和特定疾病名称 (例如",心肌梗塞"",视网膜病变").
- 通过网络药理学,体外/体内实验数据和生物材料输送系统分析核心目标.
主要成果:
- 银化物调节关键通路 (PI3K/Akt/mTOR,HIF-1α/VEGF,MAPK/NF-κB) 具有抗炎,抗氧化和抗亡作用.
- 观察到血管生成的双向调节,影响了诸如心脏修复,脑缺血,皮肤创伤,瘤和糖尿病视网膜病变等疾病.
- 将金氏化物与生物材料结合起来,促进了向的输送和受控的释放,证明了治疗效益和安全性.
结论:
- 由于多目标,双向调节,金赛诺化物显示出治疗血管生成相关疾病的巨大潜力.
- 进一步的临床研究对于验证机制和优化药物输送系统以获得精确的治疗结果至关重要.
相关概念视频
01:10Mechanism of Angiogenesis
6.7K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.7K
01:24Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.3K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.3K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
932
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
932
01:25Antihypertensive Drugs: Direct Renin Inhibitors
1.3K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.3K
01:16Antianginal Drugs: Nitrates and β-Blockers
1.4K
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
1.4K